Qube Research & Technologies (QRT)’s Karuna Therapeutics, Inc. Common Stock KRTX Stock Holding History

Qube Research & Technologies (QRT)’s Portfolio KRTX Stock Details KRTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell	-4,128	Closed	-$1.31M	–	4990
2023 Q4	$1.31M	Buy	+4,128	New	+$802K	﹤0.01%	1767
2023 Q3	–	Sell	-2,265	Closed	-$491K	–	4389
2023 Q2	$491K	Buy	+2,265	New	+$485K	﹤0.01%	1515
2022 Q4	–	Sell	-20,808	Closed	-$4.68M	–	3126
2022 Q3	$4.68M	Buy	+20,808	New	+$4.21M	0.03%	641
2021 Q3	–	Sell	-5,095	Closed	-$581K	–	2917
2021 Q2	$581K	Buy	+5,095	New	+$596K	0.01%	1205

Other funds holding KRTX

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Sachetta Lynnfield, Massachusetts $206M AUM 26.19% 1-Year Est. Return

Qube Research & Technologies (QRT)'s KRTX Position: Q1 2024 in Review

Qube Research & Technologies (QRT) sold out of Karuna Therapeutics, Inc. Common Stock (KRTX) in Q1 2024, closing a stake of 4,128 shares — an estimated $1.31M sold.

Qube Research & Technologies (QRT) first reported a position in KRTX in Q2 2021 and held it in 4 quarters. The position peaked at $4.68M in Q3 2022. 2 funds tracked by Wall St. Rank hold KRTX as of Q1 2024.

Qube Research & Technologies (QRT) reported no remaining Karuna Therapeutics, Inc. Common Stock position as of Q1 2024 after selling out during the quarter.
Qube Research & Technologies (QRT) sold 4,128 Karuna Therapeutics, Inc. Common Stock shares in Q1 2024, an estimated $1.31M.
Qube Research & Technologies (QRT) first reported a position in Karuna Therapeutics, Inc. Common Stock in Q2 2021 and held it in 4 quarters.
Qube Research & Technologies (QRT)'s Karuna Therapeutics, Inc. Common Stock position peaked at $4.68M in Q3 2022.
2 funds tracked by Wall St. Rank held Karuna Therapeutics, Inc. Common Stock as of Q1 2024.

Based on Qube Research & Technologies (QRT)'s 13F filing for Q1 2024, filed 14 May 2024.